Table 3.

Antimicrobial activity (µmol/ml) of synthesized (E)-2-(3-(substitutedstyryl)-5-(substitutedphenyl)-4,5-dihydropyrazol-1-yl)benzo[d]thiazole derivatives

Comp	B. subtilis	S. aureus	E. coli	P. aeruginosa	C. albicans	R. oryzae
Z1	0.0278	0.0278	0.0278	0.0278	0.0278	0.0278
Z2	0.0278	0.0278	0.0555	0.0069	0.0278	0.0278
Z3	0.0265	0.0265	0.0265	0.0265	0.0265	0.0265
Z4	0.0265	0.0265	0.0530	0.0265	0.0265	0.0265
Z5	0.0530	0.0265	0.0530	0.0265	0.0265	0.0265
Z6	0.0069	0.0278	0.0555	0.0278	0.0278	0.0278
Z7	0.0302	0.0302	0.0302	0.0302	0.0302	0.0151
Z8	0.0302	0.0302	0.0605	0.0302	0.0302	0.0302
Z9	0.0232	0.0232	0.0464	0.0232	0.0232	0.0232
Z10	0.0305	0.0305	0.0610	0.0305	0.0305	0.0305
Z11	0.0283	0.0283	0.0566	0.0142	0.0283	0.0283
Z12	0.0328	0.0328	0.0328	0.0164	0.0328	0.0328
Z13	0.0150	0.0299	0.0299	0.0150	0.0299	0.0299
Z14	0.0566	0.0566	0.0566	0.0566	0.0566	0.0283
Z15	0.0283	0.0283	0.0566	0.0142	0.0283	0.0283
Z16	0.0232	0.0232	0.0464	0.0232	0.0232	0.0232
Z17	0.0241	0.0241	0.0241	0.0241	0.0481	0.0241
Z18	0.0241	0.0241	0.0241	0.0241	0.0241	0.0241
Z19	0.0249	0.0249	0.0498	0.0249	0.0249	0.0249
Z20	0.0223	0.0223	0.0445	0.0223	0.0223	0.0223
STDa	0.0075	0.0075	0.0075	0.0075	0.0040	0.0040

^aCiprofloxacin (antibacterial), Fluconazole (antifungal)